
Dr. Esha Kaul
Qualification : MBBS
Specialization : Hematologist
Department : Hematology
Experience : 13+ Years
Designation : Associate Director
About Dr. Esha Kaul
Dr. Esha Kaul is an American Board Certified doctor in Internal medicine and Hematology, with a flourishing career of 14 years. She completed her MBBS from the prestigious All India Institute of Medical Sciences and went on to pursue a residency at Tufts University, Boston, USA.
Dr. Esha is credited for establishing the Bone Marrow Transplant Unit at Jaypee Hospital, Noida, wherein she has more than 100 successful Bone marrow transplants to her name.
Holding a keen interest in Multiple Myeloma and Amyloidosis, she has lent her extensive skills and knowledge to multiple pieces of research, which are now published across many national as well as international journals. Having trained and worked in the west, Dr. Esha has been actively involved in workshops, medical seminars, oral presentations, and teaching. Her work and merit have been recognized by esteemed institutions.
Education & Training
- July 2011 – June 2014 – Fellow in Division of Hematology and Oncology, Tufts Medical Center, Boston, MA.
- July 2009 – June 2011 – Resident, Department of Internal Medicine, Tufts Medical Center, Boston, MA.
- July 2008 – June 2009 – Intern, Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA.
- February 2007 – June 2007 – Junior Resident, Department of Employee Health Services, All India Institute of Medical Sciences, New Delhi, India.
- August 2001 – January 2007 – MBBS, All India Institute of Medical Sciences, New Delhi, India.
Experience
- Executive Consultant at the Department of Hematology-Oncology/Bone Marrow Transplant, JayPee Hospital, Noida (April 2016 – Present).
- Associate Consultant at the Department of Hematology- Oncology/Bone Marrow Transplant, BL Kapoor Superspeciality Hospital, New Delhi (February 2015 – February 2016).
Clinical Focus
- Bone Marrow Transplant
- Myelodysplastic disorders
- Multiple myeloma
- Amyloidosis
- Myeloproliferative disorders